1) relapse ovarian carcinoma
复发卵巢癌
1.
Ifosfamine and etoposide in 26 cases with relapse ovarian carcinoma;
异环磷酰胺与依托泊苷联合治疗26例复发卵巢癌
2) recurrent ovarian cancer
复发性卵巢癌
1.
Objective To meta-analytically compare 2-[fluorine 18]-2-deoxy-D-glucose positron emission tomography (~(18)FDG-PET) and computed tomography (CT) or magnetic resonance imaging (MRI) for diagnosis of recurrent ovarian cancer.
目的 用Meta分析(meta—analysis)的方法对国内外资料进行统计学分析,比较~(18)FDG—PET与CT及MRI在诊断复发性卵巢癌中的作用。
2.
In platinum-sensitiverecurrent ovarian cancer treatment, GEM and carboplatin treatment are more effectivethan single carboplatin drug treatment, but significantly increased hematologicaltoxicity.
目的:评价吉西他滨在复发性卵巢癌治疗过程中的疗效和安全性。
3.
Objective This study was performed to clarify the role of secondary cytoreduction in patients with recurrent ovarian cancer and to establish scoring systems intending to evaluate the survival risk and the resectability for the patients undergoing secondary cytoreduction.
目的二次细胞减灭术(Secondary Cytoreduction,SCR)在复发性卵巢癌治疗中的地位尚不明确,如何选择合适的患者进行手术仍是临床工作的难点。
3) Recurrence of ovarian cancer
卵巢癌复发灶
5) recurrent epithelial ovarian cancer
复发性卵巢上皮癌
1.
Management of recurrent epithelial ovarian cancer;
复发性卵巢上皮癌的处理
6) recurrent advanced ovarian carcinoma
复发性晚期卵巢癌
1.
Objective To observe the efficacy and toxicity of irinotecan(CPT-11) therapy of patients with recurrent advanced ovarian carcinoma.
方法24例复发性晚期卵巢癌,采用伊立替康单药化疗方案治疗。
补充资料：宫颈复发癌
宫颈复发癌
多发生于晚期宫颈癌(包括局部晚期)治疗后，也有报告浸润性宫颈癌治疗后约有35%复发。复发性宫颈癌的治疗困难，预后差，是宫颈癌死亡最重要的原因。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条